May 30, 2023 — Let’s talk about lame excuses for denial of care in obesity. Writing in Quartz yesterday, Analisa Merelli explained the challenge obesity treatment presents for health insurer. The challenge comes down to this: “The line between healthcare and lifestyle can be blurry.” In this way of thinking, insurance companies must decide if the intentions are right […]
May 28, 2023 — “Money makes the world go around.” Joel Grey and Liza Minnelli explained this in Cabaret. But sorting it out in healthcare – and specifically in obesity care right now – is quite a challenge. A lot of money is in play and so the tension between greed, health, and obesity care is painfully obvious. The […]
May 26, 2023 — Some health insurance plans seem to be panicking. For years, the order of things was simple. People with obesity had only themselves to blame and besides, nothing could be done about their condition. So health insurers routinely denied coverage for medical care of obesity. “Regardless of any potential medical benefit” was the language written into […]
May 18, 2023 — It is impossible to miss. At ECO2023, we are seeing tremendous excitement about advances in obesity care – mixed with concern about what happens when those advances meet with reality. As ECO2023 unfolds, we’re hearing more about the advances that new obesity medicines are offering, but we’re also hearing reminders about the gap between the […]
May 8, 2023 — Semaglutide for the treatment of obesity continues to be in short supply. Late last week, Novo Nordisk announced that, because the company is still having difficulty keeping up with demand, they would limit production of the lower doses used to start patients on Wegovy. Thus, compounding pharmacies are selling cheap copies of semaglutide injection and […]
May 4, 2023 — How can we possibly afford paying for all of the innovation that’s coming in obesity care? This is hardly an academic question. It’s a practical one that flickers in the minds of policymakers who balk at finding ways to make effective treatment for obesity more accessible to the people with great medical needs for it. […]
April 12, 2023 — Two innovations in health systems and health policy – PBMs and biosimilars – are supposed to save us money on drugs. But so far, it looks like the joke is on us. PBMs (pharmacy benefit managers) can actually drive prices higher. Their stated purpose is just the opposite – to drive drug costs down. Adding […]
March 28, 2023 — A close look at how health insurance denies access to care for children and youth with severe obesity reveals one thing. The system is really set up as insurance for profits – not for health. The story of Debra and Dan Tyler seeking care for one of their daughters, as reported by Ariana Eunjung Cha […]
February 24, 2023 — Obesity Care Week has come as we are in the midst of a great public re-thinking of obesity care. Feelings about this subject are strong, but facts are catching up with those feelings and causing people to reconsider old ways of thinking. The dialogue goes in many directions, but a key issue is access to […]
February 20, 2023 — Public discourse about new medicines for treating obesity is easy to find right now – and a lot of it seems unreal from our vantage point. Headlines about people “terrified” by the prospect of effective options for kids with severe obesity or debating which Hollywood stars might be taking one of these drugs are weirdly off-topic. […]
